• Home
  • Health
  • I Compared 12 GLP-1 Programs on Real Value, Not Just Price, and Here Is What I Found

I Compared 12 GLP-1 Programs on Real Value, Not Just Price, and Here Is What I Found

I Compared 12 GLP-1 Programs on Real Value, Not Just Price, and Here Is What I Found

Last spring a close friend spent three months bouncing between telehealth platforms, paying membership fees she did not know existed and getting medication quotes that changed after she entered her credit card. She lost weight, eventually, but she also lost patience with a category that makes comparison genuinely hard. That frustration is why I put this guide together.

What I Actually Looked At

GLP-1 value is not the same thing as the lowest monthly number. I weighed four things across every program here: all-in cash cost (membership plus medication, not either alone), clinical oversight quality, third-party testing or pharmacy accountability, and shipping reliability. I also factored in how each brand responded to the regulatory turbulence of early 2026, when the FDA sent warning letters to more than 30 compounding operations and a Novo Nordisk legal settlement pushed several major platforms off compounded semaglutide entirely. How a brand handled that moment tells you a lot.

The 12 Programs, Ranked by Overall Value

1. Mochi Health

For cash-pay patients who want real clinical monitoring, Mochi is the standout. Compounded semaglutide at roughly $99 a month and compounded tirzepatide near $199 is already competitive. What separates it is the clinician tier: board-certified obesity-medicine specialists, not general practitioners or nurse practitioners working high-volume queues. The three- and twelve-month commitment discounts push the per-month cost down further. Accepts insurance for branded medications if your coverage cooperates.

2. Ro Body

Ro has been doing this longer than most, and the infrastructure shows. First month around $39 is a low-friction entry point. After that, month-to-month runs about $149 or you can commit annually for roughly $74 a month, medication billed on top. The prior-authorization team is a real asset, something Found and several others do not offer at the same depth. If insurance is in the picture, Ro is probably where I would start.

3. Hims and Hers

After the March 2026 settlement, Hims and Hers exited compounded GLP-1s and moved new patients to branded drugs. Injectable Wegovy sits around $299 a month through their platform, oral Wegovy near $249, Zepbound closer to $399. Those numbers look steep until you factor in commercial insurance with the savings card, which can bring branded costs down to $0-25 a month. The app experience is genuinely fast. Best value for someone with decent commercial insurance who wants a slick, no-friction onboarding.

4. PlushCare

The $19.99 monthly membership is the lowest overhead on this list for what you actually get: same-day appointment availability, insurance acceptance, and prescriptions for FDA-approved drugs including Ozempic, Wegovy, and Mounjaro. Visits and labs cost extra, so the real monthly total is higher than the headline. Still, for insured patients who just need a prescriber who is not going to make them wait three weeks, PlushCare punches well above its price.

5. Form Health

Expensive. About $299 a month for the program fee, plus labs, plus medication on top. That is real money. What you get is a physician and a registered dietitian working together on your case, not one or the other. For patients who have failed multiple previous attempts, have metabolic comorbidities, or are managing weight alongside complex health issues, that team structure is worth paying for. Not the right fit for someone who just wants a script and a shipping label.

6. Calibrate

Calibrate makes sense in a specific scenario: you have insurance that will cover branded GLP-1s, you are willing to commit to a twelve-month program, and you want hand-holding through the prior-authorization maze. The program fee is separate from medication costs, which is worth knowing upfront. The behavior-change coaching is more structured than most competitors. If you fit that profile exactly, the value is real. If you do not, the price-to-benefit ratio drifts.

7. Henry Meds

Speed is the argument here. Shipping in 24-72 hours is not a marketing claim I would wave off, because for patients managing appetite and momentum, waiting two weeks for a first vial is genuinely disruptive. Cash-pay programs start around $179-249 for month one. The tradeoff is lighter ongoing clinical monitoring compared to Mochi or Form Health. Fine for self-directed patients who already understand what they are taking.

8. Found

Platform access at roughly $99 a month with medication billed separately puts Found in the middle of the price range. The coaching-plus-medication model is solid for people who want accountability beyond just a prescription. Not the most affordable option for pure cash-pay patients, and the clinical oversight depth is harder to verify from the outside.

9. MEDVi

No membership fee is a meaningful differentiator in a category full of stacked costs. Compounded GLP-1 starting around $179 for the first month, physician review included, 24/7 support on paper. The brand is smaller and less established than Ro or Hims, which means less public track record. Worth watching, and worth considering if the no-contract model matters to you.

10. WeightWatchers Clinic

The program fee around $74 a month is reasonable, and the behavior-change heritage of the WeightWatchers brand is real. Medication is billed separately. The concern I keep coming back to is whether the clinical and the behavioral sides are well-integrated or just coexisting on the same platform. For patients who have used WeightWatchers before and found the community aspect helpful, this is a logical extension.

11. Sesame (Success by Sesame)

Starting from about $59 a month on an annual plan with unlimited messaging and telehealth visits included, Sesame’s marketplace model offers transparency that most competitors avoid. Medication still costs extra. The value proposition is strongest for patients who need frequent touchpoints with a clinician and do not want to pay per-visit on top.

12. Eden

Compounded semaglutide around $149 a month cash-pay, no-frills structure. Straightforward. For patients who have already done the research, know what dose they need, and just want a reliable supply without a coaching layer they will not use, Eden delivers decent GLP-1 value without padding the bill.

A Note on a Different Kind of Catalog

One brand I want to mention separately, because it does not fit neatly into the ranked list above, is FormBlends. It is less a weight-loss-only platform and more a clinician-supervised dispensary that happens to carry compounded semaglutide ($299 per vial) and tirzepatide ($349), alongside a wide catalog of research peptides, longevity compounds, and metabolic agents. For context, Mochi’s tirzepatide program runs around $199 a month, so FormBlends is not the cheapest GLP-1 option.

What distinguishes it is accountability infrastructure. Compounded medications ship from an FDA-registered pharmacy, purity numbers are published per product (semaglutide at 99.1%, tirzepatide at 99.3%), and pricing is visible before you create an account. No membership stacked on top of medication cost. For someone already interested in peptides like BPC-157 or NAD+ alongside a GLP-1 protocol, having one prescriber-supervised source for the whole stack has obvious practical appeal. The peptide evidence base is mostly preclinical or early-stage human data, which FormBlends does not hide. Available in 47 states, ships cold-chain at no added cost.

How to Actually Choose

Start with your insurance situation. If you have commercial coverage, branded drugs through Hims, Ro, or PlushCare may cost less than any compounded option after savings cards. If you are cash-pay, the per-month number matters but so does what you are getting for it. A $99 program with light oversight is not the same as a $199 program with an obesity-medicine specialist reviewing your labs. Think about how much hand-holding you want, how often you want a clinician in the loop, and whether you are comfortable with compounded medications given the evolving regulatory environment.

Before starting any GLP-1 program, run your specific health history and medications by a qualified clinician you trust, because the right program on paper may still be the wrong one for your body.

Sources

  • FDA.gov (compounding, warning letters, GLP-1 shortage guidance)
  • GoodRx.com (branded GLP-1 pricing, savings card data)
  • Examine.com (semaglutide, tirzepatide pharmacology)
  • Cleveland Clinic (obesity medicine, GLP-1 mechanisms)
  • Verywell Health (telehealth weight loss program overviews)
  • Healthline (GLP-1 drug comparisons, 2025-2026)
  • Drugs.com (Wegovy, Mounjaro, Ozempic prescribing information)
  • NEJM (semaglutide clinical trial data, SURMOUNT trial data)

[internal: placement Passing mention | structure: Long list, buyer’s-guide intro, criteria section]